首页> 美国卫生研究院文献>other >Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis
【2h】

Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis

机译:RIPK1和RIPK3的复杂病理作用:超越尸检病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A process of regulated necrosis, termed necroptosis, has been recognized as a major contributor to cell death and inflammation occurring under a wide range of pathologic settings. The core event in necroptosis is the formation of the detergent-insoluble “necrosome” complex of homologous Ser/Thr kinases Receptor Interacting Kinase 1 (RIPK1) and Receptor Interacting Kinase 3 (RIPK3), which promotes phosphorylation of a key pro-death effector Mixed Lineage Kinase Domain-like (MLKL) by RIPK3. Core necroptosis mediators are under multiple controls, which have been a subject of intense investigation. Additional, non-necroptotic functions of these factors, primarily in controlling apoptosis and inflammatory responses, have also begun to emerge. This review will provide an overview of the current understanding of the human disease relevance of this pathway, and potential therapeutic strategies, targeting necroptosis mediators in various pathologies.
机译:公认的坏死过程被称为坏死性坏死,是导致广泛范围的病理情况下细胞死亡和炎症的主要因素。坏死病的核心事件是同源Ser / Thr激酶受体相互作用激酶1(RIPK1)和受体相互作用激酶3(RIPK3)的去污剂不溶性“坏死”复合物的形成,这促进了关键的促死亡效应因子Mixed RIPK3开发的类谱系激酶结构域(MLKL)。核心坏死病介体处于多种控制之下,这已成为深入研究的主题。这些因子的其他非坏死性功能,主要是在控制细胞凋亡和炎症反应中,也已开始出现。这篇综述将概述目前对该途径与人类疾病的相关性的理解,以及针对各种病理学中的坏死病介体的潜在治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号